Fortis Healthcare growth over the years

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Compounded a year1 yr3 yr
Revenue+17.3%+13.2%
EBITDA+31.3%+23.7%
Net Income+31.5%+18.9%
EPS (adj.)+34.6%+20.9%
Total Assets+16.6%+8.7%
Total Equity+10.9%+7.9%
Free Cash Flow+13.8%+20.5%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

FORTIS₹754.90

Fortis Healthcare Ltd.

· Pharma & Health
₹ CrorePeersAPOLLOHOSPMAXHEALTHMEDANTAAUROPHARMALUPINALKEMLAURUSLABSMANKINDMcap ₹56,992 Cr
Annuals · FY-end closes
Compounded Growth
Annuals · CAGR %
1Y
CAGR
3Y
CAGR
Revenue+17.3+13.2
EBITDA+31.3+23.7
Net Income+31.5+18.9
EPS (adj.)+34.6+20.9
Total Assets+16.6+8.7
Total Equity+10.9+7.9
Free Cash Flow+13.8+20.5
CAGR from filed annuals — needs positive start & end values.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.